abstract |
SUBSTITUTED Heterocyclic Ethers and Their Use in CNS Disorders. The present invention relates to compounds of Formula 1, including pharmaceutically acceptable salts thereof, their pharmaceutical compositions and their use in the treatment of CNS disorders. |